C60507 |
Clone integrant minimum 20 percent representation value |
Value, as a percentage, of the representation among all clones/integrants of the clones/integrants at the specified gene or flanking gene location, for clones/integrants comprising >=20 percent of all clones/integrants.
|
Supplemental |
1.00 |
2021-04-22 14:46:13.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60508 |
Clone integrant minimum 20 percent representation genetic location |
Location, relative to other genes on a DNA strand, of any clone(s) or integrant(s) having >=20 percent representation within the population of clones and integrants.
|
Supplemental |
1.00 |
2021-04-22 16:30:50.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60509 |
Insertional oncogene near clone integrant minimum 20 percent representation name |
Name(s) of the gene(s) associated with insertional oncogenesis within or near which are located clone(s) or integrant(s) that have >=20 percent representation among the population of all clones and integrants.
|
Supplemental |
1.00 |
2021-04-22 16:41:29.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60510 |
Cell clone proportional increase last two analysis indicator |
Indicator of whether any cell clones have increased in proportion over the last two analyses.
|
Supplemental |
1.00 |
2021-04-22 16:49:24.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60511 |
Cell clone proportional increase last two analysis identifier text |
Text field for identifying cell clone(s) that have increased as a proportion of the population of clones over the last two analyses.
|
Supplemental |
1.00 |
2021-04-22 16:51:48.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60512 |
Cell clone proportional increase last two analysis previous proportion percent value |
Value as a percent of the proportion of all cell clones, that the specified cell clone showing proportional increase over the last two analyses presented during the previous analysis.
|
Supplemental |
1.00 |
2021-04-22 16:53:58.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60513 |
Cell clone proportional increase last two analysis current proportion percent value |
Value as a percent of the proportion of all cell clones, that the specified cell clone showing proportional increase over the last two analyses presented during the current (i.e., most recent) analysis.
|
Supplemental |
1.00 |
2021-04-22 16:53:58.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60514 |
Gene modified hematopoiesis best characterize type |
Type of condition that best characterizes the observed gene-modified hematopoiesis.
|
Supplemental |
1.00 |
2021-04-23 10:54:46.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60515 |
Gene edit frequency text |
Text field for capturing the frequency with which gene editing was performed.
|
Supplemental |
1.00 |
2021-04-23 11:03:20.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60516 |
Gene edited hematopoietic stem progenitor cells blood CD3 depleted indicator |
Indicator of whether the gene-edited hematopoietic stem and progenitor cells (HSPC) blood is depleted of CD3.
|
Supplemental |
1.00 |
2021-04-22 13:21:58.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60517 |
Gene edited hematopoietic stem progenitor cells blood CD3 depleted conversion percent value |
Value of the percentage of conversions related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood.
|
Supplemental |
1.00 |
2021-04-23 11:09:53.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60518 |
Gene edited hematopoietic stem progenitor cells blood CD3 depleted on target indel count |
Count of on-target indels related to CD3 depletion in gene-edited hematopoietic stem and progenitor cells (HSPC) in blood.
|
Supplemental |
1.00 |
2021-04-23 11:12:55.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60519 |
Gene editing conversion blood CD3 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD3+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60519 |
Gene editing conversion blood CD3 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD3+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60520 |
Gene editing conversion blood CD19 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD19+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60520 |
Gene editing conversion blood CD19 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD19+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60521 |
Gene editing conversion blood CD15 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD15+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60521 |
Gene editing conversion blood CD15 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD15+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60522 |
Gene editing conversion blood GPA plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood GPA+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60522 |
Gene editing conversion blood GPA plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood GPA+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60523 |
Gene editing conversion blood CD14 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD14+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60523 |
Gene editing conversion blood CD14 plus lineage percent value |
Value of the percentage of gene-editing conversions in the blood CD14+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60524 |
Gene editing blood CD3 plus lineage on target indel count |
Count of gene-editing on-target indels in the blood CD3+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60524 |
Gene editing blood CD3 plus lineage on target indel count |
Count of gene-editing on-target indels in the blood CD3+ lineage.
|
Core |
1.00 |
2021-04-23 11:20:12.0 |
Gene Product Follow-Up |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|
C60525 |
Gene editing blood CD19 plus lineage on target indel count |
Count of gene-editing on-target indels in the blood CD19+ lineage.
|
Supplemental |
1.00 |
2021-04-23 11:20:12.0 |
Genotoxicity |
False |
Sickle Cell Disease |
Sickle Cell Disease |
|